Co-Authors
This is a "connection" page, showing publications co-authored by Benjamin tenOever and Shu Horiuchi.
Connection Strength
0.350
-
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021 03 09; 54(3):557-570.e5.
Score: 0.232
-
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2. Stem Cell Reports. 2021 09 14; 16(9):2274-2288.
Score: 0.060
-
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng. 2021 08; 5(8):815-829.
Score: 0.059